Guide for Authors

 

Aims and scope of the journal

Before submission, please ensure your manuscript fits the aims and scope of the Journal of Basic and Clinical Veterinary Medicine (JBCVM).

The JBCVM aims to basic and clinical veterinary sciences by publishing and promoting high-quality, refereed research and clinical articles. The JBCVM welcomes original contributions, including articles, short contributions, reviews, case series, clinical updates, and letters to the editor on all aspects of veterinary sciences and medicine.

The originality and quality of the research and its significance to the authors are the most important acceptance criteria for all papers.

Editorial review process

Plagiarism Detection

The peer-review process is at the heart of the success of scientific publishing, as part of our commitment to the protection and enhancement of the peer-review process.

 The editorial board is very strict regarding plagiarism. The journal believes that taking the ideas and work of others without giving them credit is unfair and dishonest. Copying even one sentence from someone else's manuscript, or even one of your own that has previously been published, without proper citation is considered plagiarism-use your own words instead. The editorial board retains the absolute authority to reject the review process of a submitted manuscript if it subject to minor or major plagiarism and even may cancel the publication upon the complaint of victim(s) of plagiarism.

Manuscripts must be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals available at http://www.icmje.org/.

We will do our best to ensure that all articles are peer-reviewed, under the guidelines of the World Association of Medical Editors (http://www.WAME.org), the International Association of Veterinary Editors (http://www.veteditors.org), and the Committee on Publication Ethics (COPE) (http://publicationethics.org/resources/guidelines).

For reviewing of the submitted manuscript, Assistant Editor sends it to at least two expert referees. After completion of the review process, finally, Editor-in-Chief makes decisions on the eligibility of a manuscript for publication. JBCVM reserves the right to reject any manuscript.

Materials published in the JBCVM, unless otherwise stated, reflects the view of the author(s) only and not that of the JBCVM, the editors, the Editorial Advisory Boards, the referees, or our sponsors and host institutes.

Submitting an article:

Submit all manuscripts electronically through http://www.jbcvm.iaurmia.ac.ir

Select the Submit manuscript tab on top of the page and follow the instructions to create an account or log in.

Failure to comply with the instructions will result in the return of the manuscript and delay in processing, review, and publication. Please double-check that you have followed the instructions, reviewed the quality of the image files, and the formatting of the manuscript and the references (see below for details of the references).

Requirements for submission

In order to submit, authors must state the following in their cover letter to the Editor-in-Chief:

  • They should confirm that the manuscript has been submitted solely to the JBCVM and is not published, in press or submitted elsewhere in any shape or format. Short published conference abstracts are excepted from this rule. Information on prior or duplicate publication of parts of the research elsewhere of any part of the paper should be announced.
  • They should declare that all the research meets the ethical guidelines of the study country; animal use or handling for research purposes or clinical interventions must meet the requirements of the EU (http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32010L0063), or Canada (https://www.ccac.ca/Documents/Standards/Guidelines/Experimental_Animals_Vol1.pdf ) and veterinary code of practice.
  • Any real or potential conflict of interest, including the source of any grants, consultancies or any other funding should be declared clearly. Also, the contribution of all authors should be stated and all authors’ agreement with the content of the manuscript should be spelled out.
  • A statement explaining why the manuscript should be considered for publication in the JBCVM.
  • Note: submission checklist is as below: 
  • Title page (Mandatory)
  • Manuscript main file (Mandatory)
  • Cover letter (Mandatory) (Click on  Cover_letter  to download)
  • English abstract (Mandatory)
  • Persian abstract (Mandatory). This part is not essential for non-Iranian authors
  • Table(s) (Optional)
  • Figure(s) (Optional)

Authorship

Eligibility for authorship should be based only on substantial contributions to 1) conception and design, or analysis and interpretation of data, and 2) drafting the article or revising it critically for important intellectual content. For example, for a clinician or lab-based researcher to be included as an author of an article, he/she should have contributed to the conception and/or interpretation of clinical/paraclinical data, drafted relevant sections of the article, and engaged in critical review and revision of the whole article. General supervision of the research group, or participation in the acquisition of funding or the collection of data, do not in themselves justify authorship. We take complaints of authorship seriously and may choose to support a legal process if we notice any misconduct.

Ethical considerations

Submission of manuscripts to the JBCVM confirms that the protocol for the research project has been approved by a properly constituted Scientific and  Ethics Committee of the institution within which the work was undertaken. The handling and use of animals in experiments must conform to the regulations stated above. The approval number from an animal experimentation ethics committee should be included in the Materials and methods section.

If human subjects were involved in research (e.g., surveys, sensory panels, or other participation), the authors must certify that the studies complied with all appropriate laws, regulations, and policies governing the use of human subjects in research.

The JBCVM retains the right to reject any manuscript on the basis of the unethical conduct of either human or animal studies.

The submission also requires the submission of ARRIVE guidelines for in vivo experiments.

Title

The title should be concise, specific, and informative, but should not make extreme claims about the conclusions of the study. Avoid including geographical locations unless they are of epidemiological significance. Only capitalize the first letter of the title.

Authors’ names and addresses

List each author’s full name should be cited. Separate the authors’ names with a comma, except for the last two authors, which are separated with ‘and’ (e.g. Edward Allen Smith1, Ali-Reza Mohammadi Sani1, and Yoko Watanabe1,2*).

Include the addresses of the institutions at which the work was carried out and indicate the authors’ affiliations with those institutions using superscript numbers (as above). Indicate the corresponding author with an asterisk (* as above). Include all author’s email address and the corresponding author’s postal and email addresses.

Abstract

Up to 250 words following the general format of the article. Sufficient information must be provided such that the abstract is a stand-alone document. The abstracts should contain the following subtopics:

Background, Hypothesis(es), Materials and Methods, Results, Conclusions

Note: Iranian authors should submit the Persian abstract on a separate page.

Keywords

Keywords should appear after the abstract. Use the heading ‘Keywords’ and then up to 5 keywords separated by semi-colons.

Abbreviations

Abbreviations are used only if the term is used three or more times. All abbreviations must be written out in full the first time they appear in the text, followed by the abbreviation in brackets. Exceptions are SI units and commonly used terms that can be understood from the context, for example, IV, SC, IM, DNA, RNA, EDTA, IgA, IgG.

Acknowledgments

All sources of funding and support should be acknowledged. Authors should acknowledge only significant intellectual and technical contributions, and permission from those listed should be obtained before publication.

Conflict of interest and funding

All sources of potential conflict of interest (simply defined as something that would embarrass the authors or make them liable to legal processes, should it become known after publication) and funding should be acknowledged.

References

We use the reference style outlined by the International Committee of Medical Journal Editors (ICMJE), also referred to as the “Vancouver” style. Number references in the text consecutively with superscript Arabic numerals that follow any punctuation marks. Journal name abbreviations should be those found in the National Centre for Biotechnology Information (NCBI) databases.

Cite references to unpublished work only in the text, with a notation of (personal communication) or (unpublished data). Please send a copy of any cited work that is included in the reference list as "in press". It is the authors' responsibility to check the accuracy of reference citations.

Tables

Tables should be self-contained and complement the information contained in the text. They must not duplicate information in the text and should only be necessary if the material is too complicated to be written out.

Type the legend above the relevant table. Column headings should be brief, with units of measurement in brackets. All abbreviations must be defined in footnotes to the table. Use superscript lower case letters to mark footnotes (a, b, c, etc.) and superscript capital letters to mark statistical significance (A, B, C, etc.).

Construct tables such that the “x” variable is on the left and the “y” variable is across the top. This makes reading easier in the absence of grid lines.

Number tables with Arabic numerals consecutively in the order they occur in the text. Refer to the table in the text as (Table 2). Do not use a sentence to simply direct the reader to the table. Notify the reader indirectly with an informative sentence.

Figures

Include figures only if they are informative and necessary for the understanding of the text. Figures must be uploaded as individual files and in a figure format (jpg, tiff, etc) of resolution of at least 600 dpi at 8.6 cm wide.

Number figures consecutively in the order they occur in the text, with Arabic numerals. Refer to the figure in the text as (Figure 3). Do not use a sentence to simply direct the reader to the table. Notify the reader indirectly with an informative sentence.

Microscopy images should be able to show the details that that are mentioned in the legend at a print width of 8.6 cm (single column). Scale bars must be included on micrographs; or alternatively, the objective magnification (e.g. 10x, 100x, etc.) should be stated.

Digital manipulation of an image is acceptable only if it is done to enhance photographic density or to eliminate artifacts. Any digital manipulation must be mentioned in the figure legend. The author(s) must also state in the covering letter that the scientific content of the image has not been altered. The editor may need to examine the original image.

Article types and word counts

Original articles are the work of the authors, rather than simply reporting the work of others fit the definition of “research;” i.e defined as the creation of new knowledge and/or the use of existing knowledge in a new and creative way so as to generate new concepts, methodologies and understandings. This could include synthesis and analysis of previous research to the extent that it leads to new and creative outcomes to be consistent with the aims and scope of the journal.

Opinion papers or a simple collection of readily available information with no original research or critique from the author(s) that do not add to the knowledge of experts in the field are accepted. Please look at a recent issue of the journal to see the elements of each article type.

 In general, articles will follow the IMRD system – introduction, materials and methods, results and discussion. The original article's words limit is 4000.

Introduction – set the premise for study, give sufficient background to justify study, state objective(s) and hypothesis if the study is hypothesis-driven.

Materials and methods – state methods in enough detail for readers to reproduce work. For observational studies, data manipulation is the main focus of the methods and must be described in detail.

Results – succinctly report the results, provide sufficient detail that data analysis can be replicated, refer to figures and tables when necessary (do not duplicate results).

Discussion – interpret and critique findings that relate to objectives, do not present new data, do not over-interpret results nor propose mechanisms beyond the scope of the study. Finish with appropriate conclusion, again, relative to objective(s).

Conclusion – summarise findings considering objective(s). the conclusion can be a short paragraph or the last paragraph of the discussion.

Acknowledgments – acknowledge funding, technical support etc.

Conflict of interest – any financial or non-financial association with any authority or company that may be a source of conflict must be spelled out. JBCVM reserves the right to delete publications and announce the reason for the deletion of such papers if we find out about such associations.

References (up to 60).

Tables and images. Up to 4 tables or images

Legends – Legends should be descriptive and non-interpretative; and as short as possible.

Critical reviews and meta-analyses (maximum 5000 words) – the relevant literature must be critiqued (in light of the question posed) examining the relevance and validity of findings and conclusions. You must source original information (i.e. do not include other reviews).

We encourage evidence-based reviews that critically evaluate the effect of specified treatments or interventions on defined conditions form a valuable part of evidence-based medicine. References (up to 70). Up to 6 tables or images

Clinical review and case reports/series (maximum 1500 words) - Case reports must be novel and concern a rare or new condition; and reasons for publication and merits should be justified. Case reports that do not add substantially to the existing literature will not be published. The first published example in any country that is well recognized elsewhere, is not necessarily of sufficient value unless justified by explaining to the Editor. References (up to 15). Up to 2 tables or images

Descriptions should be brief and clear. The clinical features should be convincing and robust that would reject other plausible diagnoses. Reference ranges for laboratory tests conducted must be.

Clinical features – history and clinical findings, diagnosis, treatment, and outcome.

Short communication (maximum 1200 words) - Novel observations and interpretations that can be summarised due to non-extensive experiments and materials and methods. References (up to 15). Tables and images. Up to 2 tables or images

Letters to the Editor (maximum 1000 words):  Letters that address a certain professional issue or a paper published in VJES are welcome. The Editor in Chief reserves the right to not publish any letter, or communicate about it with any eligible body. Letters should be submitted via direct email and with the subject as ‘Letter to the Editor’.

We appreciate the freedom of opinion and speech; however, such letters cannot defame or maliciously slander individuals or bring false claims against persons/organizations, endorse a commercial product. Claims must be referenced as per other papers. Contact details of the authors of the letters must be included to enable prompt processing and verification of their letters. Defamatory letters and those containing false claims will be forwarded to our legal consultants for advice. The correctness and validity of the claims is the responsibility of the author(s).

We may suggest changes to the text of such letters and if the original author is prepared to accept suggested revisions, the Editor in Chief will send a revised draft to the author for confirmation and signoff.

Supplementary material (online only)

Authors can present material online that cannot physically be printed but can be linked to the article. These can be videos, detailed tables or series of images.  Appropriate reference should be made within the text and highlighted upon submission to create the link. Supplementary materials should be submitted and go through the review process with the paper. Reviewers may also request such materials.

Style

Manuscripts should be written in a clear, concise, direct style so that they are intelligible to the professional reader (for example a general practitioner) who is not a specialist in a particular field.

Papers should be written in English, submitted as a Word document with double spacing and pages numbered. Times New Roman font must be used throughout the text, tables, and figure legends. Do not use ‘Enter’ at the end of lines within a paragraph. Do not underline any text or image.

Use concise English without jargon or colloquialisms. Avoid long sentences. We recommend using computer spelling and grammar checking programs. It is recommended that the manuscript is critically read by a colleague experienced in scientific authorship, but who is not directly involved in the study, before submitting it to VJES.

The authors are responsible for the correct format and suitable standard of English. Papers will be returned without review if the English is not of a sufficient standard. Authors for whom English is a second language may choose to have their manuscript professionally edited before submission or during the review process. We offer English language editing services. Should you require such services, please note in your submission letter. However, using this service does not guarantee that your paper will be accepted.

All manuscripts are edited to eliminate ambiguity and repetition, to improve communication between author and reader, for length, and to conform to the required style. If extensive alterations are required, the manuscript will be returned to the author for revision. To avoid unnecessary delays with the publication, the editors reserve the right to make alterations to text in the final draft of accepted papers.

Spelling and units

The AVJ uses American spelling and authors should follow the latest edition of Saunders Comprehensive Veterinary Dictionary.

Use SI metric system (e.g. ha, min, °C) where applicable. Write dates in the form “26 Jul 2018” and currency in the form €44 or $33. Use a comma as a thousand spacer in numbers of more than four digits (e.g. 11,000).

Abbreviations

Use abbreviations only if the term is used >3 times. All abbreviations are to be written out in full the first time they appear in the text, followed by the abbreviation in brackets. Exceptions are SI units and commonly used terms that can be understood from the context, for example:

PCR, ELISA, IV, SC, IM, DNA, IgG

Trade names

Mention the manufacturer and essential location information for drugs, reagents, and equipment in parentheses within the text (e.g. Ziest-Chemie, Iran) or (IBM, USA).

The scientific naming of organisms and microorganisms

Organisms and microorganisms must be correctly named with genus and species, where appropriate. The full name of the microorganism should be used the first time it is (e.g. Salmonella typhi), thereafter it should be abbreviated to genus initial and species name (e.g. S. typhi); followed by strain name/ number (if available). All scientific names are in italic font.

Copyright license agreement

By submitting your paper to JBCVM, the authors agree to the following copyright license agreement, if their paper is accepted in JBCVM:

All authors must read and agree to the conditions outlined in the agreement. You may receive a copy of the agreement to sign and the corresponding author can sign on their behalf.

Proofs

The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at the PDF proof stage. The proof should be checked and approval to publish the article should be submitted to the JBCVM by the date indicated.

Note: There is no charge for article submitting and publication.

Contact the JBCVM office:

E-mail: jbcvm@iaurmia.ac.ir